Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$11.97 -1.0%	$12.72	$5.11 ▼ $19.22	$335.03M	1.03	235,054 shs	218,203 shs
OBIO Orchestra BioMed	$2.83 -4.1%	$3.01	$2.37 ▼ $8.87	$108.43M	0.67	165,375 shs	212,619 shs
OM Outset Medical	$17.61 -9.7%	$13.14	$5.85 ▼ $72.60	$312.08M	1.9	107,791 shs	252,878 shs
TMCI Treace Medical Concepts	$5.86 +0.2%	$7.09	$4.54 ▼ $10.79	$368.54M	0.79	604,479 shs	338,690 shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	-3.59%	-0.58%	-17.81%	-14.86%	+119.42%
OBIO Orchestra BioMed	+4.61%	+7.66%	+13.03%	-35.16%	-57.68%
OM Outset Medical	+3.78%	+4.84%	+67.96%	+78.72%	-67.34%
TMCI Treace Medical Concepts	-3.94%	-7.00%	-15.22%	-35.93%	+15.84%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLPT ClearPoint Neuro	1.8506 of 5 stars	3.5	2.0	2.6	0.0	0.6
OBIO Orchestra BioMed	3.0754 of 5 stars	4.6	4.0	2.2	0.8	0.0
OM Outset Medical	2.4814 of 5 stars	3.5	5.0	2.3	0.8	0.0
TMCI Treace Medical Concepts	2.3258 of 5 stars	3.1	1.0	2.3	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	3.00	Buy	$25.00	108.86% Upside
OBIO Orchestra BioMed	3.20	Buy	$14.20	401.77% Upside
OM Outset Medical	3.00	Buy	$27.00	53.32% Upside
TMCI Treace Medical Concepts	2.29	Hold	$10.16	73.33% Upside

Current Analyst Ratings Breakdown

Latest OBIO, TMCI, CLPT, and OM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/21/2025	OM Outset Medical	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$14.00 ➝ $21.00
5/15/2025	OM Outset Medical	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/13/2025	OBIO Orchestra BioMed	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00
5/9/2025	TMCI Treace Medical Concepts	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$10.00 ➝ $8.60
5/8/2025	OM Outset Medical	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$12.00 ➝ $14.00
5/5/2025	OBIO Orchestra BioMed	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$16.00 ➝ $12.00
4/23/2025	OBIO Orchestra BioMed	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/22/2025	OBIO Orchestra BioMed	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00
4/11/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$9.50 ➝ $8.00
4/4/2025	OBIO Orchestra BioMed	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$14.00 ➝ $12.00
4/3/2025	OBIO Orchestra BioMed	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$32.24M	10.39	N/A	N/A	$0.86 per share	13.92
OBIO Orchestra BioMed	$2.89M	37.57	N/A	N/A	$1.90 per share	1.49
OM Outset Medical	$115.27M	2.71	N/A	N/A	$2.45 per share	7.19
TMCI Treace Medical Concepts	$210.82M	1.75	N/A	N/A	$2.24 per share	2.62

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$22.09M	-$0.76	N/A	N/A	N/A	-59.64%	-62.10%	-38.39%	8/6/2025 (Estimated)
OBIO Orchestra BioMed	-$49.12M	-$1.78	N/A	N/A	N/A	-2,179.33%	-107.04%	-70.88%	N/A
OM Outset Medical	-$172.80M	-$29.15	N/A	∞	N/A	-112.57%	-175.64%	-38.61%	8/6/2025 (Estimated)
TMCI Treace Medical Concepts	-$49.53M	-$0.85	N/A	N/A	N/A	-30.33%	-51.12%	-26.36%	8/5/2025 (Estimated)

Latest OBIO, TMCI, CLPT, and OM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2025	Q1 2025	CLPT ClearPoint Neuro	-$0.15	-$0.22	-$0.07	-$0.22	$8.21 million	$8.49 million
5/12/2025	Q1 2025	OBIO Orchestra BioMed	-$0.46	-$0.49	-$0.03	-$0.49	$0.39 million	$0.87 million
5/8/2025	Q1 2025	TMCI Treace Medical Concepts	-$0.31	-$0.25	+$0.06	-$0.25	$52.07 million	$52.57 million
5/7/2025	Q1 2025	OM Outset Medical	-$0.97	-$3.66	-$2.69	-$3.66	$27.81 million	$29.75 million
3/31/2025	Q4 2024	OBIO Orchestra BioMed	-$0.43	-$0.43	N/A	-$0.43	$0.79 million	$0.25 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
OBIO Orchestra BioMed	N/A	N/A	N/A	N/A	N/A
OM Outset Medical	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	N/A	4.54	3.61
OBIO Orchestra BioMed	N/A	4.23	4.21
OM Outset Medical	4.12	6.49	5.04
TMCI Treace Medical Concepts	0.51	4.12	2.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
OBIO Orchestra BioMed	53.55%
OM Outset Medical	N/A
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.97%
OBIO Orchestra BioMed	8.10%
OM Outset Medical	2.40%
TMCI Treace Medical Concepts	27.72%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	27.99 million	25.90 million	Optionable
OBIO Orchestra BioMed	4	38.31 million	35.47 million	Not Optionable
OM Outset Medical	520	17.72 million	51.50 million	Not Optionable
TMCI Treace Medical Concepts	250	62.89 million	47.08 million	Optionable

OBIO, TMCI, CLPT, and OM Headlines

Recent News About These Companies

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 29 at 12:25 PM | accessnewswire.com

TMCI LAWSUIT ALERT: The Gross Law Firm Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

May 29 at 12:13 PM | globenewswire.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 29 at 11:00 AM | accessnewswire.com

Investor Alert: Deadline Approaching to Join Treace Medical Concepts, Inc. (TMCI) Class Action - Contact Levi & Korsinsky

May 29 at 7:30 AM | accessnewswire.com

TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

May 29 at 7:00 AM | accessnewswire.com

The Gross Law Firm Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMCI

May 29 at 5:45 AM | prnewswire.com

Investor Alert: Deadline Approaching to Join Treace Medical Concepts, Inc. (TMCI) Class Action – Contact Levi & Korsinsky

May 28 at 4:30 PM | accessnewswire.com

Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) Over Securities Violations - Contact Levi & Korsinsky Today

May 28 at 2:45 PM | accessnewswire.com

TMCI DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action – TMCI

May 28 at 2:23 PM | globenewswire.com

Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Shareholders of Class Action Lawsuit and June 10, 2025 Deadline

May 28 at 12:15 PM | accessnewswire.com

Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

May 28 at 12:00 PM | prnewswire.com

Shareholders of Treace Medical Concepts, Inc. (TMCI): Protect Your Rights Before June 10, 2025 - Contact Levi & Korsinsky

May 28 at 10:45 AM | accessnewswire.com

Recover Investment Losses: Levi & Korsinsky Files Class Action Against Treace Medical Concepts, Inc. (TMCI)

May 28 at 7:15 AM | accessnewswire.com

TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

May 28 at 7:00 AM | accessnewswire.com

TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors - Lead Plaintiff Deadline June 10, 2025

May 27 at 4:30 PM | accessnewswire.com

ROSEN, A LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

May 27 at 4:12 PM | markets.businessinsider.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 27 at 2:40 PM | accessnewswire.com

ROSEN, A LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

May 27 at 2:23 PM | accessnewswire.com

Investors Urged to Contact Levi & Korsinsky for Information Before June 10, 2025 - Treace Medical Concepts, Inc. (TMCI)

May 27 at 12:30 PM | accessnewswire.com

TMCI ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Treace Medical Concepts, Inc. - June 10, 2025 Deadline

May 27 at 11:00 AM | accessnewswire.com

BNP Paribas Financial Markets Makes New $590,000 Investment in Treace Medical Concepts, Inc. (NASDAQ:TMCI)

May 26 at 3:21 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OBIO, TMCI, CLPT, and OM Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$11.97 -0.12 (-0.99%)

Closing price 04:00 PM Eastern

Extended Trading

$11.96 -0.01 (-0.04%)

As of 04:10 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Orchestra BioMed NASDAQ:OBIO

$2.83 -0.12 (-4.07%)

Closing price 04:00 PM Eastern

Extended Trading

$2.82 0.00 (-0.18%)

As of 04:04 PM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Outset Medical NASDAQ:OM

$17.61 -1.89 (-9.69%)

Closing price 04:00 PM Eastern

Extended Trading

$17.74 +0.14 (+0.77%)

As of 04:33 PM Eastern

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Treace Medical Concepts NASDAQ:TMCI

$5.86 +0.01 (+0.17%)

Closing price 04:00 PM Eastern

Extended Trading

$5.86 0.00 (0.00%)

As of 04:04 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time